Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU2-57P is a human genomic locus annotated as RNA, U2 small nuclear 57, pseudogene. It belongs to the large family of U2 snRNA pseudogenes, which are noncoding, non-functional genomic remnants of the U2 snRNA gene. Unlike their functional counterparts (e.g., RNU2-1, RNU2-2) that contribute to the core structure and activity of the spliceosome essential for pre-mRNA splicing in eukaryotes, pseudogenes like RNU2-57P do not produce active snRNAs or proteins and are generally not transcribed, translated, or directly implicated in cellular processes[1][2][3][4][5]. Their biological and pharmacological relevance is limited to infrequent research into genetic regulation or genome evolution, not therapeutic intervention.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 57, pseudogene (RNU2-57P).